An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients-Reference-Cited by-同舟云学术

An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients

Published:2012-05 Issue:5 Volume:23 Page:1207-1213
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Crea F.,Fornaro L.,Paolicchi E.,Masi G.,Frumento P.,Loupakis F.,Salvatore L.,Cremolini C.,Schirripa M.,Graziano F.,Ronzoni M.,Ricci V.,Farrar W.L.,Falcone A.,Danesi R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/5/1207/13785594/mdr387.pdf

Reference37 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Palliative treatment of unresectable metastatic colorectal cancer;Fornaro;Expert Opin Pharmacother,2010

3. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer;Köhne;Oncologist,2009

4. Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009;Van Cutsem;Ann Oncol,2010

5. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients;Kohne;Ann Oncol,2002

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients;Discover Oncology;2024-08-29

2. A genetic variant in the immune-related gene ERAP1 affects colorectal cancer prognosis;Chinese Medical Journal;2023-09-08

3. EZH2 Expression and Survival for ER+/tamoxifen Treated Breast Cancer Patients with rs2302427 C>G: A Novel Prognostic and Risk Predictive Biomarker;Archives of Medical Research;2023-07

4. The role of epigenetic modifications in Colorectal Cancer Metastasis;Clinical & Experimental Metastasis;2022-04-16

5. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials;Signal Transduction and Targeted Therapy;2019-12